This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2007-2009.
Company Filing History:
Years Active: 2007-2009
Title: Fabrizio Badalassi: Innovator in Androgen Receptor Modulation
Introduction
Fabrizio Badalassi is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of selective androgen receptor modulators. With a total of 2 patents, Badalassi's work is paving the way for advancements in medical treatments.
Latest Patents
His latest patents include "Aminophenyl derivatives as selective androgen receptor modulators," which discloses a novel class of aminophenyl compounds. These compounds have the potential to treat or prevent conditions related to androgen receptors. Another significant patent is "Androgen receptor modulators and method of treating disease using the same," which details bicycloaryl compounds that selectively modulate nuclear receptors, particularly the androgen receptor. This patent outlines methods for treating diseases by administering these compounds to patients in need.
Career Highlights
Fabrizio Badalassi is currently employed at Acadia Pharmaceuticals Inc., where he continues to innovate in the field of drug development. His work focuses on creating effective treatments that can significantly improve patient outcomes.
Collaborations
He collaborates with talented coworkers, including Nathalie Schlienger and Jan Pawlas, who contribute to the research and development efforts at Acadia Pharmaceuticals Inc.
Conclusion
Fabrizio Badalassi's contributions to the field of androgen receptor modulation highlight his role as a key innovator in pharmacology. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.